Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
RepliGut
Sort By
Newest First
1 / 1
1 / 1
Tissue Models
Exploring Pharmacokinetics and Safety for Drugs Targeting the Gut
Altis Biosystems
PAO-04-22-R250-03
Apr 01, 2022
Research Funding
Altis Biosystems Awards New Research Funding to Armed Forces Radiobiology Research Institute
Altis Biosystems
PR-M02-22-09
Feb 09, 2022
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Ron Laethem, Ph.D.
Altis Biosystems
PAO-02-21-CL-04
Feb 18, 2021
Tissue Models
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Bailey Zwarycz, Ph.D
Altis Biosystems
PA1081
Jan 26, 2021
Preclinical
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
Ron Laethem, Ph.D.
Altis Biosystems
PAO-11-20-CL-01
Dec 09, 2020
Gene Editing
Enhancing Human Gut Tissue Models through Gene Editing
Scott Magness, Ph.D.
Altis Biosystems
PAO-11-20-CL-03
Nov 30, 2020
Microbiome
Evaluating Microbiome Therapies with Intestinal Cell Models
Scott Magness, Ph.D.
Altis Biosystems
PAO-10-20-CL-02
Oct 22, 2020
Microphysiological Systems
Accelerating Drug Development with Microphysiological Systems (MPS)
Nancy Allbritton, Ph.D., M.D.
Altis Biosystems
PAP-Q3-20-CL-003
Sep 29, 2020
